Concepts (221)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Medicine | 2 | 2019 | 46 | 1.240 |
Why?
|
| Asthma | 10 | 2019 | 984 | 0.740 |
Why?
|
| Cystic Fibrosis | 13 | 2014 | 115 | 0.720 |
Why?
|
| Pediatrics | 1 | 2019 | 361 | 0.480 |
Why?
|
| Child | 24 | 2019 | 7242 | 0.310 |
Why?
|
| Child, Preschool | 10 | 2019 | 3773 | 0.280 |
Why?
|
| Infant | 7 | 2019 | 3189 | 0.250 |
Why?
|
| Echocardiography | 6 | 1990 | 944 | 0.240 |
Why?
|
| Adolescent | 20 | 2019 | 9347 | 0.200 |
Why?
|
| Genetic Counseling | 2 | 2014 | 102 | 0.200 |
Why?
|
| Cardiomegaly | 4 | 1990 | 120 | 0.190 |
Why?
|
| Disclosure | 2 | 2014 | 109 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 2 | 1990 | 144 | 0.150 |
Why?
|
| Respiration | 2 | 2013 | 267 | 0.140 |
Why?
|
| Genetic Predisposition to Disease | 7 | 2013 | 2360 | 0.140 |
Why?
|
| Lung | 4 | 2013 | 1292 | 0.130 |
Why?
|
| Genotype | 4 | 2008 | 1852 | 0.110 |
Why?
|
| Transmembrane Activator and CAML Interactor Protein | 1 | 2013 | 8 | 0.110 |
Why?
|
| beta-Defensins | 1 | 2013 | 12 | 0.110 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 38 | 0.110 |
Why?
|
| Humans | 33 | 2019 | 90014 | 0.110 |
Why?
|
| Chemokines, CC | 1 | 2013 | 37 | 0.110 |
Why?
|
| Genetic Testing | 3 | 2014 | 543 | 0.110 |
Why?
|
| Chromosome Mapping | 3 | 2004 | 1074 | 0.100 |
Why?
|
| Consensus | 1 | 2014 | 366 | 0.100 |
Why?
|
| Respiratory Function Tests | 4 | 2013 | 140 | 0.100 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2003 | 63 | 0.100 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2013 | 2415 | 0.100 |
Why?
|
| Agriculture | 1 | 2011 | 40 | 0.090 |
Why?
|
| Sweat | 1 | 2011 | 5 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 2 | 2008 | 77 | 0.090 |
Why?
|
| Rural Population | 1 | 2011 | 149 | 0.090 |
Why?
|
| Comprehension | 1 | 2011 | 81 | 0.090 |
Why?
|
| Neonatal Screening | 1 | 2011 | 65 | 0.080 |
Why?
|
| Male | 22 | 2014 | 42705 | 0.080 |
Why?
|
| Erythrocyte Transfusion | 1 | 1990 | 73 | 0.080 |
Why?
|
| Female | 23 | 2014 | 46617 | 0.080 |
Why?
|
| Adult | 20 | 2013 | 26836 | 0.080 |
Why?
|
| Blood Transfusion | 1 | 1990 | 171 | 0.080 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 1979 | 69 | 0.080 |
Why?
|
| Parents | 1 | 2011 | 290 | 0.070 |
Why?
|
| Lymphangiectasis, Intestinal | 1 | 1986 | 2 | 0.070 |
Why?
|
| Protein-Losing Enteropathies | 1 | 1986 | 6 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2008 | 235 | 0.070 |
Why?
|
| Hemodynamics | 1 | 1990 | 738 | 0.070 |
Why?
|
| Pleural Effusion | 1 | 1986 | 47 | 0.070 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1986 | 41 | 0.070 |
Why?
|
| Allergens | 2 | 2005 | 183 | 0.070 |
Why?
|
| Genetic Carrier Screening | 3 | 2014 | 59 | 0.060 |
Why?
|
| Family Health | 2 | 2003 | 162 | 0.060 |
Why?
|
| Eukaryota | 1 | 2005 | 46 | 0.060 |
Why?
|
| Skin Tests | 2 | 2003 | 44 | 0.060 |
Why?
|
| Antigens, Dermatophagoides | 1 | 2005 | 11 | 0.060 |
Why?
|
| Docosahexaenoic Acids | 1 | 2005 | 32 | 0.060 |
Why?
|
| Integrin beta3 | 1 | 2005 | 32 | 0.060 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 1984 | 8 | 0.060 |
Why?
|
| Triglycerides | 1 | 2005 | 233 | 0.060 |
Why?
|
| Tobramycin | 1 | 2004 | 9 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2004 | 125 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2004 | 201 | 0.060 |
Why?
|
| Lung Abscess | 1 | 1983 | 5 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2004 | 227 | 0.050 |
Why?
|
| Inhalation | 1 | 1983 | 31 | 0.050 |
Why?
|
| Immunoglobulin E | 1 | 2003 | 145 | 0.050 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 2658 | 0.050 |
Why?
|
| Lung Diseases | 1 | 2004 | 275 | 0.050 |
Why?
|
| Cimetidine | 2 | 1984 | 7 | 0.050 |
Why?
|
| Heterozygote | 1 | 2003 | 373 | 0.050 |
Why?
|
| Hyperthyroidism | 1 | 1982 | 75 | 0.050 |
Why?
|
| Genetic Heterogeneity | 1 | 2001 | 67 | 0.050 |
Why?
|
| Founder Effect | 2 | 2014 | 104 | 0.050 |
Why?
|
| Pancreatic Extracts | 1 | 1980 | 1 | 0.050 |
Why?
|
| Pulmonary Heart Disease | 1 | 1980 | 4 | 0.050 |
Why?
|
| Guanidines | 1 | 1980 | 31 | 0.050 |
Why?
|
| Cockroaches | 1 | 2000 | 10 | 0.040 |
Why?
|
| HLA-DR Antigens | 1 | 2000 | 59 | 0.040 |
Why?
|
| Receptors, Interleukin-4 | 1 | 2000 | 9 | 0.040 |
Why?
|
| Insect Proteins | 1 | 2000 | 89 | 0.040 |
Why?
|
| Environment | 1 | 2001 | 225 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 1982 | 196 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2001 | 624 | 0.040 |
Why?
|
| Anti-Bacterial Agents | 1 | 2004 | 799 | 0.040 |
Why?
|
| Genome, Human | 1 | 2003 | 791 | 0.040 |
Why?
|
| Infant, Newborn | 4 | 2011 | 2497 | 0.040 |
Why?
|
| Forced Expiratory Volume | 2 | 1994 | 126 | 0.040 |
Why?
|
| Stroke Volume | 3 | 1990 | 479 | 0.040 |
Why?
|
| Lung Diseases, Obstructive | 1 | 1978 | 19 | 0.040 |
Why?
|
| Aorta | 1 | 1979 | 289 | 0.040 |
Why?
|
| Genetic Variation | 2 | 2005 | 1380 | 0.040 |
Why?
|
| Heart Atria | 1 | 1979 | 282 | 0.040 |
Why?
|
| Cardiac Volume | 2 | 1990 | 53 | 0.030 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 1994 | 56 | 0.030 |
Why?
|
| Membrane Proteins | 2 | 1994 | 1227 | 0.030 |
Why?
|
| Expectorants | 1 | 1996 | 6 | 0.030 |
Why?
|
| Deoxyribonuclease I | 1 | 1996 | 28 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 18 | 0.030 |
Why?
|
| Phenotype | 3 | 2008 | 2457 | 0.030 |
Why?
|
| Homozygote | 1 | 1994 | 200 | 0.030 |
Why?
|
| Immunity, Mucosal | 1 | 2013 | 70 | 0.030 |
Why?
|
| Fatty Acids | 2 | 1986 | 134 | 0.030 |
Why?
|
| Lod Score | 2 | 2003 | 152 | 0.030 |
Why?
|
| Nuclear Family | 2 | 2003 | 93 | 0.030 |
Why?
|
| Body Weight | 2 | 1986 | 453 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2008 | 1868 | 0.020 |
Why?
|
| South Dakota | 1 | 2011 | 47 | 0.020 |
Why?
|
| Mutation | 2 | 1994 | 4169 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 872 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 365 | 0.020 |
Why?
|
| Hemoglobinometry | 1 | 1990 | 8 | 0.020 |
Why?
|
| Health Education | 1 | 2011 | 105 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 6418 | 0.020 |
Why?
|
| Molecular Sequence Data | 3 | 2001 | 3024 | 0.020 |
Why?
|
| Aged | 3 | 2013 | 19272 | 0.020 |
Why?
|
| Myocardial Contraction | 1 | 1990 | 252 | 0.020 |
Why?
|
| Cerebrovascular Disorders | 1 | 1990 | 145 | 0.020 |
Why?
|
| United States | 3 | 2013 | 7114 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2011 | 6787 | 0.020 |
Why?
|
| Chitinase-3-Like Protein 1 | 1 | 2008 | 9 | 0.020 |
Why?
|
| Adipokines | 1 | 2008 | 17 | 0.020 |
Why?
|
| Pulmonary Ventilation | 1 | 2008 | 33 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1075 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1990 | 983 | 0.020 |
Why?
|
| Lectins | 1 | 2008 | 84 | 0.020 |
Why?
|
| Haplotypes | 2 | 2000 | 637 | 0.020 |
Why?
|
| Middle Aged | 3 | 2013 | 26173 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1250 | 0.020 |
Why?
|
| Body Constitution | 1 | 1987 | 26 | 0.020 |
Why?
|
| Heart Function Tests | 1 | 1987 | 33 | 0.020 |
Why?
|
| Rosette Formation | 1 | 1986 | 34 | 0.020 |
Why?
|
| Ventricular Function | 1 | 1987 | 53 | 0.020 |
Why?
|
| Linoleic Acids | 1 | 1986 | 3 | 0.020 |
Why?
|
| Linoleic Acid | 1 | 1986 | 5 | 0.020 |
Why?
|
| Alleles | 2 | 2000 | 1137 | 0.020 |
Why?
|
| Drug Therapy, Combination | 2 | 1996 | 785 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 1990 | 613 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1986 | 27 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 1986 | 100 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1986 | 143 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1986 | 178 | 0.020 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2005 | 7 | 0.020 |
Why?
|
| Heart Ventricles | 2 | 1982 | 786 | 0.020 |
Why?
|
| Prognosis | 1 | 1994 | 3800 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 2005 | 63 | 0.020 |
Why?
|
| Reference Values | 1 | 1987 | 662 | 0.020 |
Why?
|
| Biological Availability | 1 | 2005 | 91 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2013 | 1691 | 0.020 |
Why?
|
| Intestinal Absorption | 1 | 2005 | 125 | 0.020 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2005 | 41 | 0.020 |
Why?
|
| Hospitalization | 2 | 2004 | 888 | 0.020 |
Why?
|
| Safety | 1 | 2005 | 145 | 0.020 |
Why?
|
| Pancreatic Function Tests | 1 | 1984 | 7 | 0.020 |
Why?
|
| Aminobenzoates | 1 | 1984 | 5 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2005 | 108 | 0.020 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 1984 | 6 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2005 | 124 | 0.010 |
Why?
|
| Gene Frequency | 2 | 2000 | 687 | 0.010 |
Why?
|
| HLA-G Antigens | 1 | 2004 | 52 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1986 | 468 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 305 | 0.010 |
Why?
|
| Cough | 1 | 2004 | 55 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 3684 | 0.010 |
Why?
|
| Administration, Inhalation | 1 | 2004 | 192 | 0.010 |
Why?
|
| Fever | 1 | 2004 | 127 | 0.010 |
Why?
|
| Eubacterium | 1 | 1983 | 2 | 0.010 |
Why?
|
| Peptostreptococcus | 1 | 1983 | 3 | 0.010 |
Why?
|
| Family Relations | 1 | 2003 | 36 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 200 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1987 | 1732 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 377 | 0.010 |
Why?
|
| Cardiac Output | 1 | 1982 | 155 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1929 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 2001 | 40 | 0.010 |
Why?
|
| Biomarkers | 1 | 2008 | 1778 | 0.010 |
Why?
|
| Family | 1 | 2003 | 324 | 0.010 |
Why?
|
| Chromosomes, Human | 1 | 2001 | 65 | 0.010 |
Why?
|
| Africa | 1 | 2001 | 101 | 0.010 |
Why?
|
| Maximal Midexpiratory Flow Rate | 1 | 1980 | 1 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2004 | 1497 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 1211 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1987 | 1255 | 0.010 |
Why?
|
| Europe | 1 | 2001 | 324 | 0.010 |
Why?
|
| HLA-DRB1 Chains | 1 | 2000 | 25 | 0.010 |
Why?
|
| Survival Rate | 1 | 2004 | 1899 | 0.010 |
Why?
|
| Genetic Markers | 1 | 2001 | 476 | 0.010 |
Why?
|
| Christianity | 1 | 2000 | 37 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2000 | 79 | 0.010 |
Why?
|
| Immunization | 1 | 2000 | 163 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1979 | 36 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1979 | 270 | 0.010 |
Why?
|
| Diastole | 1 | 1979 | 142 | 0.010 |
Why?
|
| Pedigree | 1 | 2001 | 969 | 0.010 |
Why?
|
| Lipids | 1 | 1980 | 275 | 0.010 |
Why?
|
| Angiography | 1 | 1979 | 208 | 0.010 |
Why?
|
| Linkage Disequilibrium | 1 | 2000 | 477 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2000 | 528 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 948 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2004 | 8292 | 0.010 |
Why?
|
| Cardiac Catheterization | 1 | 1979 | 307 | 0.010 |
Why?
|
| Celiac Disease | 1 | 1980 | 214 | 0.010 |
Why?
|
| Decision Making | 1 | 2003 | 671 | 0.010 |
Why?
|
| Heart Rate | 1 | 1979 | 498 | 0.010 |
Why?
|
| Cytomegalovirus Infections | 1 | 1978 | 150 | 0.010 |
Why?
|
| Aerosols | 1 | 1996 | 47 | 0.010 |
Why?
|
| Heart | 1 | 1979 | 578 | 0.010 |
Why?
|
| Time Factors | 1 | 2004 | 5361 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1978 | 958 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1008 | 0.010 |
Why?
|
| Acute Disease | 1 | 1996 | 846 | 0.010 |
Why?
|
| Research | 1 | 1995 | 251 | 0.010 |
Why?
|
| Prospective Studies | 1 | 1982 | 4329 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1992 | 93 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1996 | 1714 | 0.010 |
Why?
|
| Oxygen | 1 | 1996 | 746 | 0.010 |
Why?
|
| Age Factors | 1 | 1995 | 1880 | 0.010 |
Why?
|
| Base Sequence | 1 | 1992 | 2329 | 0.000 |
Why?
|
| Chicago | 1 | 1992 | 1434 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1979 | 9237 | 0.000 |
Why?
|
| Amylases | 1 | 1984 | 14 | 0.000 |
Why?
|
| para-Aminobenzoates | 1 | 1984 | 6 | 0.000 |
Why?
|
| Isoenzymes | 1 | 1984 | 274 | 0.000 |
Why?
|
| Animals | 1 | 2000 | 27536 | 0.000 |
Why?
|